Prospective voluntary clinical research that supports carbohydrate restriction and aerobic exercise and supports physical condition improvement for untreated patients who are pointed out hyperuricemia by medical checkups.

Prospective voluntary clinical research that supports carbohydrate restriction and aerobic exercise and supports physical condition improvement for untreated patients who are pointed out hyperuricemia by medical checkups. - Prospective clinical research that supports physical condition improvement for untreated hyperuricemia.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000037135

Enrollment

500

Registered

2019-06-23

Start date

2019-07-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperuricemia

Interventions

(1)Conventional dietary guidance only group (2)Aerobic exercise group after intiatinon of carbohydrate restriction diet (3)Carbohydrate restriction after initiation of aerobic exercise

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Target patients who meet all the following criteria 1) Hyperuricemia patients (untreated patients: UA value 7 mg / dL or more) 2) Patients of 20 years or older at the time of obtaining consent (regardless of gender) 3) Patients who obtained written consent by their own free will after receiving sufficient explanation for participating in this study 4) Patients who have used smartphone usually and have a email address

Exclusion criteria

Exclusion criteria: Patients who conflict with any of the following will not be included in this study 1) Patients who have already received drug treatment for hyperuricemia 2) Patients who received treatment for hyperuric acid treatment up to 3 months ago and have been discontinued. 3) Patients who have received medical treatment such as diabetes (including boundary type) 4) Patients with a history of myocardial infarction 5) Patients with a history of coronary revascularization (PCI or CABG) 6) Patients with unstable angina 7) Patients with a history of cerebrovascular disease (except asymptomatic lacunar infarction) 8) Patients who have been hospitalized for heart failure 9) Patients with severe liver disease (AST (GOT) or ALT (GPT)> 100 U) 10) Patients with severe renal disease (BUN 25 mg / dL or more or serum creatinine 2.0 mg / dL or more) 11) Pregnant and nursing women 12) Any patient who the research director has judged inappropriate as a research subject

Design outcomes

Primary

Measure	Time frame
Amount of change in UA value at study start and 6 months after	—

Countries

Japan

Contacts

Public ContactShuichi YOSHIDA

Sendai Tokushukai Hospital orthopedic surgery

syoshida@miyagi.med.or.jp022-372-1110

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026